Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
about
The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1EgoNet: identification of human disease ego-network modulesNovel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.E3 ubiquitin ligase isolated by differential display regulates cervical cancer growth in vitro and in vivo via microRNA-143.Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinomaRole of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.Screening of potentially crucial genes and regulatory factors involved in epithelial ovarian cancer using microarray analysisAkt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach.
P2860
Q24297359-076E629F-D227-4D2B-8F76-1CD24F04815AQ34525552-39D6E853-8414-4694-BDAD-40F84E19BCE9Q34775779-A1AF6AF9-DF80-4C8A-870D-54EF2E5FC8DEQ35093544-4959241D-7486-4596-AE0A-DA12B51D1540Q35178414-EFD56FA3-9E2B-4217-A633-C4CAB7243AFAQ36544617-577A8782-F12E-4C9A-8C22-F3DAF201E82AQ36798094-A66ACD86-CAC5-433F-BC34-903F47DDD82CQ37108561-4173A951-7A5D-444C-9C9D-FC31DF3A650AQ37215827-0A7F0AF0-8AC1-442B-8EA0-7AFD7A9202F3Q37452434-05CDF616-EAFB-4A30-A4FE-9D6C3BF96519Q37660331-686CA297-BF6D-4F4A-BC76-A2E310EB5B81Q38686022-B0925B48-3C05-4781-8F6B-0AB7BB2B68A1Q38963051-9F432524-2E3F-4796-9B17-91A02CB3B665Q39267923-E672CF8A-5FEB-477F-9975-08F0569ACB5DQ52869251-CC9098AC-2BE1-43E9-9335-222F6643E18BQ54259614-55A2A772-1E74-45EA-A161-6DA999B06EA4
P2860
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@en
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@nl
type
label
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@en
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@nl
prefLabel
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@en
Characterization of DOK1, a ca ...... in epithelial ovarian cancer.
@nl
P2093
P2860
P1433
P1476
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer
@en
P2093
Bernard Têtu
Isabelle Bairati
Jean Gregoire
Karim Ghani
Magdalena Bachvarova
Marie Plante
Marie-Claude Renaud
Pierre-Luc Mercier
P2860
P304
P356
10.1016/J.MOLONC.2011.07.003
P577
2011-07-26T00:00:00Z